Orasis is funded by a diverse group of sophisticated investors with proven track records in the healthcare space.

In September 2020, Orasis closed a Series C financing co-led by Bluestem Capital and Visionary Ventures.


Visionary Ventures
Visionary Ventures is a later-stage venture fund focused on investing in drugs and devices for the eye. Visionary employs a unique approach to venture investing by partnering with over 40 key opinion leader ophthalmologists, as well as other sophisticated investors and industry professionals.
Bluestem Capital
With more than 95 years of collective experience, Bluestem Capital is a private equity and venture capital firm with 25 portfolio companies. Healthcare is a leading investment area for the firm, with continued emphasis on eyecare innovation.
Sequoia Capital
Sequoia Capital is a global venture capital firm focusing on the technology and healthcare industry.
SBI (Japan) Innovation Ventures
SBI (Japan) Innovation Fund is a biopharma focused venture capital fund that invests in Israeli venture-backed biopharma companies with cutting-edge science.
LifeSci Venture Partners
LifeSci Venture Partners is the venture investing arm of LifeSci Partners, a unique life sciences and healthcare consultancy.
Maverick Ventures Israel
Maverick Ventures Israel invests in Israeli companies with cutting edge innovations.